FDA publishes discussion paper and seeks public input on 3D printing of medical devices at the point of care

FDA

10 December 2021 - Today, the U.S. FDA published a discussion paper regarding 3D printing medical devices at the point of care, such as hospitals and doctor’s offices. 

The discussion paper does not constitute guidance; instead, its purpose is to gather feedback from the public to inform future policy development.

Read FDA in Brief

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Guidelines , Device , Consultation